Ann: Positive IHL-675A in vivo results and FDA Pathway, page-106

ime003. We are on the cusp of something extraordinary here imo . There are many great posters that have contributed to the knowledge on this thread and perhaps helped shareholders stay the course through their knowledge . We should all be grateful for that . We should also raise a glass to the sticky hand shareholders and the BOD . I am really looking forward to the next few months and how the BOD progress their strategy and how commercialise what they will have on successful FDA approval . no doubt big pharmaceutical attention will be attracted .